In contrast, METTL3 contributes to pancreatic cancer development by promoting SMS mRNA degradation via the METTL3-IGF2BP3 axis in an m6A-dependent manner (Guo et al., 2022). Here, IGF2BP3 is linked to familial pancreatic carcinoma.